The ecosystem

Biopharma

Development of therapeutic or prophylactic agents for the treatment or prevention of various diseases (oncology, neurology, infection, metabolic diseases, autoimmune diseases, etc.). This strategic activity also aims to develop activities related to the research and development of molecules (drug discovery, preclinical activities, clinical trials)

Cell Therapy

Development of innovative therapies to regenerate, repair or replace a human organ or tissue. The focus relies on cell therapy and tissue engineering applied to osteoarticular, cardiac, neurodegenerative, oncology, and autoimmune diseases.
 

Radiation applied to health

Use of ionizing radiation (external sources or isotopes) for the diagnosis and treatment of cancers. This strategic axe includes the development of imaging-based devices, biomarkers and decision support tools.

Medical devices and in vitro diagnostics

Devices, equipment, apparatus and reagents intended for (1) providing, by means of an in vitro test, information relating to the physiological or pathological condition of a patient (in vitro diagnosis) or (2) enabling monitoring, relief, treatment of a pathology, injury or handicap by means other than pharmacological (medical device). This strategic business area also includes the development of their digital components.

Biomanufacturing

Biomanufacturing supports the fields of (Bio)pharmacy and Regenerative Medicine.

It is related to the production of agents for diagnostic or therapeutic purposes by living organisms (bacteria, yeasts, cells of higher organisms).
This ​​strategic activity focuses on three pillars: the engineering of organizations, the processes (design and optimization) and the equipment needed to form the production chain.

Data-driven Science

This strategic business area aims to develop a large-scale data exploitation (Big Data) and artificial intelligence to improve health approaches, including personalized medicine.